Trenschel, R <br/><br/>
Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation.  [electronic resource] 

 -  Bone marrow transplantation  Mar 2005 
 - 583-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1704859  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antifungal Agents--therapeutic use<br/>C-Reactive Protein--analysis<br/>Caspofungin<br/>Creatine--blood<br/>Drug Evaluation<br/>Drug Therapy, Combination<br/>Echinocandins<br/>Female<br/>Fever--drug therapy<br/>Graft vs Host Disease--drug therapy<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Lipopeptides<br/>Male<br/>Middle Aged<br/>Mycoses--drug therapy<br/>Peptides, Cyclic--therapeutic use<br/>Retrospective Studies<br/>Salvage Therapy<br/>Transplantation, Homologous